CA2095499A1 - Medicament-retard - Google Patents

Medicament-retard

Info

Publication number
CA2095499A1
CA2095499A1 CA002095499A CA2095499A CA2095499A1 CA 2095499 A1 CA2095499 A1 CA 2095499A1 CA 002095499 A CA002095499 A CA 002095499A CA 2095499 A CA2095499 A CA 2095499A CA 2095499 A1 CA2095499 A1 CA 2095499A1
Authority
CA
Canada
Prior art keywords
chloro
oxepino
trans
pyrrole
dibenz
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002095499A
Other languages
English (en)
Inventor
Petrus J. M. Van Den Oetelaar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of CA2095499A1 publication Critical patent/CA2095499A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA002095499A 1992-05-08 1993-05-04 Medicament-retard Abandoned CA2095499A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92201319 1992-05-08
EP92201319.8 1992-05-08

Publications (1)

Publication Number Publication Date
CA2095499A1 true CA2095499A1 (fr) 1993-11-09

Family

ID=8210598

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002095499A Abandoned CA2095499A1 (fr) 1992-05-08 1993-05-04 Medicament-retard

Country Status (8)

Country Link
JP (1) JPH0656840A (fr)
KR (1) KR930023338A (fr)
AU (1) AU3846293A (fr)
CA (1) CA2095499A1 (fr)
FI (1) FI932088A (fr)
MX (1) MX9302711A (fr)
NO (1) NO931671L (fr)
ZA (1) ZA933134B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100330942B1 (ko) * 1994-03-02 2002-11-16 악조 노벨 엔.브이. 설하또는협측투여용약학조성물
CN1146422C (zh) * 1998-09-30 2004-04-21 伊莱利利公司 2-甲基-噻吩并-苯并二氮杂�制剂
DE10041479A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
GB0216416D0 (en) * 2002-07-15 2002-08-21 Novartis Ag Organic compounds
US6987111B2 (en) * 2003-08-06 2006-01-17 Alkermes Controlled Therapeutics, Ii Aripiprazole, olanzapine and haloperidol pamoate salts
AR077225A1 (es) * 2009-06-24 2011-08-10 Organon Nv Formulaciones inyectables que contienen asenapina y metodo de tratamiento que las utiliza
JP2021014404A (ja) * 2017-10-13 2021-02-12 アステラス製薬株式会社 トリアゾロピラジン誘導体の塩及び結晶

Also Published As

Publication number Publication date
ZA933134B (en) 1993-11-30
FI932088A0 (fi) 1993-05-07
NO931671D0 (no) 1993-05-07
NO931671L (no) 1993-11-09
JPH0656840A (ja) 1994-03-01
AU3846293A (en) 1993-11-11
KR930023338A (ko) 1993-12-18
MX9302711A (es) 1994-05-31
FI932088A (fi) 1993-11-09

Similar Documents

Publication Publication Date Title
EP0569096A1 (fr) Préparation de dépôt
KR850001883B1 (ko) 결정성 벤조티아진 디옥시드 염류의 제조방법
JPH0621070B2 (ja) ジアゼピン含有医薬組成物
JPS62215527A (ja) アルツハイマー病治療薬
US4468400A (en) Antiulcer tricyclic imidazo [1,2-a]pyridines
JPS5923313B2 (ja) （＋）カテキンの水溶性複塩およびその製造方法
FI96421C (fi) Menetelmä substituoidun karboksyylihapon farmaseuttisesti käyttökelpoisen kodeiinisuolan valmistamiseksi
CZ292423B6 (cs) Krystalický, bezvodý mykofenolát mofetilu a intravenózní prostředek, ve kterém je obsažen
HU193348B (en) Process for producing piroxicam salts of antiflogistic activity
CA2095499A1 (fr) Medicament-retard
JP2526059B2 (ja) 抗潰瘍剤
EP0497001B1 (fr) Ester alkylique de glutathion de type oxydé
EP0767777B1 (fr) Nouveaux sels d'acide 2-[(2,6-dichlorophenyl)amine]phenylacetoxyacetique a cations basiques organiques
JP3086007B2 (ja) 利尿作用を有する医薬品およびその製造方法ならびに新規の３，７−ジアザビシクロ〔３．３．１〕ノナン化合物およびその製造方法
SU1122225A3 (ru) Способ получени кристаллической водорастворимой негигроскопичной этилендиаминовой,моноэтаноламиновой или диэтаноламиновой соли @ -(2-пиридил)-2-метил-4-окси-2 @ -1,2-бензтиазин-3-карбоксамид-1,1-диоксида
CA2532805A1 (fr) Composition pharmaceutique
US4551463A (en) Composition containing 1-phenyl-1,8-naphthridin-2(1H)-ones and a non-steroidal anti-inflammatory drug
US4612310A (en) Antirheumatically active suppositories
KR910016331A (ko) 허혈성 질환 치료제
JPH05112463A (ja) 白内障治療剤
CA1311477C (fr) Esters de l'acide 1-hydroxy-5-oxo-5h-pyrido¬3,2a| phenoxazine-3-carboxylique
CA1072969A (fr) Produits hypolipidemiants a base d'acides p-aminobenzoiques
US4450161A (en) Pyrimidone salt and its preparation
KR920003580B1 (ko) 동맥경화증 예방 및 치료제
JPH0680582A (ja) 脂質代謝改善剤

Legal Events

Date Code Title Description
FZDE Dead